An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)

Name: An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)
Published: 2016
License: Public Domain

ViiV Healthcare · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

efficacy hiv-1 hiv-infections human-immunodeficiency-virus infection safety

infection, human immunodeficiency virus, hiv infections, safety, treatment naïve, hiv 1, dolutegravir plus lamivudine, non inferiority, tolerability, dolutegravir plus tenofovir/emtricitabine, efficacy, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)

Related documents